Intensity Therapeutics In... (INTS)
NASDAQ: INTS
· Real-Time Price · USD
0.33
-0.25 (-43.01%)
At close: Jun 12, 2025, 3:59 PM
13F Institute Ownership
Total Institutes of 20 in Intensity Therapeutics expanded their positions with an increase of 0 investors compared to the previous quarter. An additional 980.09K shares, as total invested capital declined by $1.86M with ownership percentage increasing from 12.61% to 19.56%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 8.10% | 1.13M | +100.00% | 1.98M | 0.03% |
| Sapient Capital LLC | 6.78% | 942.84K | -6.72% | 1.66M | 0.03% |
| Vanguard Group Inc | 1.50% | 208.89K | +0.00% | 369.73K | < 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.